Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Plunges 3%; BSE HEALTHCARE Index Up 0.9%
Mon, 25 Nov 10:40

Jubilant Pharmova Plunges 3%; BSE HEALTHCARE Index Up 0.9%Image source: bluebay2014/www.istockphoto.com

Jubilant Pharmova share price has plunged 3% and is presently trading at Rs 1,106.3.

Meanwhile, the BSE HEALTHCARE index is at 43,363.7 (up 0.9%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 2.0%) and SUN PHARMA ADV. RES. (down 1.3%).

J.B.Chemicals (up 3.7%) and POLY MEDICURE (up 3.6%) are among the top gainers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 430.3 to Rs 1,106.3, registering a gain of Rs 676.1 (up 157.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,757.1 to 43,363.7, registering a gain of 45.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 157.1%), SUVEN PHARMACEUTICALS (up 115.7%) and Glenmark Pharma (up 92.0%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 80,391.8 (up 1.6%).

The top gainers among the BSE Sensex today are L&T (up 4.0%) and SBI (up 3.6%). The most traded stocks in the BSE Sensex are Power Grid Corp. and Tata Steel.

In the meantime, NSE Nifty is at 24,320.0 (up 1.7%). Bharat Electronics and BPCL are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,930.8 to 80,391.8, registering a gain of 14,461.1 points (up 21.9%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 93.2% YoY to Rs 1,026 million for the quarter ended September 2024, compared to a profit of Rs 531 million a year ago. Net sales rose 4.3% to Rs 17,523 million during the period as against Rs 16,803 million in July-September 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 30.8.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Plunges 3%; BSE HEALTHCARE Index Up 0.9%". Click here!